Tour de France - Same support cast for Cavendish

Mark Cavendish will have the same lead-out train at the Tour de France as he had at the Giro d’Italia after the Omega Pharma-Quickstep team confirmed their team.

Tour de France - ORICA-GreenEDGE name three debutants in squad

View photo

Sprint Feature Cavendish 2013

Tony Martin, Matteo Trentin and Gert Steegmans are the men charged with helping the Brit add to his tally of 23 Tour de France stage victories and 41 Grand Tour stage wins in total.

"Cav is there to try and win stages, and of course one of the big goals of Mark is to go for the yellow jersey on the first day," Rolf Aldag, the team's sport and development manager said.

"Mark will be able to count on the same lead-out of the Giro d'Italia. They are already tested in race situations and will be ready again. Steegmans will be the last man, and Matteo Trentin will be the second to last man. But, all the team will be committed with Mark when the stage will fit his characteristics. Tony Martin will be there to ride to the 'Flamme Rouge' on the flat stages. He will bring Matteo, Gert and Cav into the best position possible in the final kilometre.”

Michal Kwiatkowski, who impressed during the Spring Classics, will make his debut with Sylvain Chavanel, Jerome Pineau, Niki Terpstra and Peter Velits completing the team.

"Tony will also be there to get his chances at the time trials," Aldag said. "The first ITT will be a little more appropriate for his skills. The second will be difficult, but for sure he will still try his best. He will also be an important piece to our TTT as he is the world champion of this discipline, so we will rely on his strength to lead us during this stage.

"Kwiatkowski is the youngest guy of the team," Aldag said. "We decided to bring him because it's time to get this kind of experience, to try and wear the white jersey even for a limited time. It will be a kind of dream for him and of course a great achievement for the team."

The 100th Tour de France begins in Corisca on June 29.

View comments (4)